News

Pfizer Limited announced that it will discontinue the marketing, distribution, and sale of Minipress XL effective September 7, 2026, following a decision by Pfizer Inc. USA to discontinue the manufacture of the drug, and will receive a lump sum payment of USD 13.9 million, equivalent to Rs 131.38 crore, from Pfizer Inc. USA.

Net profit of Pfizer rose 6.63% to Rs 204.47 crore in the quarter ended June 2026 as against Rs 191.75 crore during the previous quarter ended June 2025. Sales rose 8.31% to Rs 653.17 crore in the quarter ended June 2026 as against Rs 603.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales653.17603.05 8 OPM %37.9034.83 - PBDT290.94273.94 6 PBT276.68259.53 7 NP204.47191.75 7 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 28 July 2026.

Pfizer announced that the 75th Annual General Meeting(AGM) of the company will be held on 28 July 2026.

Pfizer announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 75 per equity Share (i.e. 750%) , subject to the approval of the shareholders.